Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The Cranbury, New Jerseybased biotech announced FDA acceptance of its Biologics License Application for RP-L201 (marnetegragene autotemcel), an investigational lentiviral vector (LV)-based gene therapy for LAD-I, a rare, genetic immune disorder that predisposes patients to frequent and often fatal infections
For gut-specific applications, some protocols use oral BPC-157 arginate at higher doses of 0.5 to 1mg daily
Limited Availability for Liquid Rhinoplasty Nose Reshaping Liquid Rhinoplasty Reshape and refine the nose without surgery using precise filler placement
The peptide has the potential to improve the collateralization and density of fibroblasts in the sites of injury in research involving rat tendons
US$ 26.33
US$ 20.50
US$ 23.67
US$ 25.28
US$ 25.47
US$ 29.68
